Veracyte (VCYT) Change in Receivables (2012 - 2026)

Veracyte (VCYT) has 15 years of Change in Receivables data on file, last reported at $5.6 million in Q1 2026.

• Quarterly Change in Receivables fell 21.07% year-over-year to $5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$778000.0 (down 111.12% YoY) and the FY2025 annual result came in at $708000.0, down 88.95% from the prior year.
• Change in Receivables climbed to $5.6 million in Q1 2026 per VCYT's latest filing, from -$3.2 million in the prior quarter.
• The five-year high for Change in Receivables was $7.1 million in Q1 2025, with the low at -$3.2 million in Q4 2025.
• Average Change in Receivables over 5 years is $781647.1, with a median of $139000.0 recorded in 2022.
• The widest YoY moves for Change in Receivables: up 448.92% in 2023, down 383.72% in 2023.
• Veracyte's Change in Receivables stood at $139000.0 in 2022, then soared by 448.92% to $763000.0 in 2023, then slumped by 360.94% to -$2.0 million in 2024, then tumbled by 58.21% to -$3.2 million in 2025, then soared by 276.73% to $5.6 million in 2026.
• Business Quant data shows VCYT's Change in Receivables at $5.6 million in Q1 2026, -$3.2 million in Q4 2025, and -$425000.0 in Q3 2025.